RSV Vaccine

• 1/30/2025

  Beyond the Bear: 3 Key Factors to Revive Moderna’s Fortunes

• 1/23/2025

  Can Moderna Bounce Back from Its COVID Crash?

• 1/18/2025

  Vaccine Demand Slump Hits Moderna’s Bottom Line

• 1/17/2025

  Moderna’s COVID Vaccine Sales Slump: Revenue Forecast Plummets $1 Billion

• 1/16/2025

  Moderna’s Vaccine Empire Crumbles: Shares Tumble Amid Revenue Warning

• 1/16/2025

  Moderna’s New Direction: Navigating Change and Driving Growth

• 12/22/2024

  Biotech Breakthroughs on a Budget: 3 Stocks to Watch

• 11/11/2024

  Moderna’s Q3 Surprise: Vaccine Demand Woes Overshadow Revenue Growth

• 11/8/2024

  Moderna Surges Ahead: Surprise Profit and Covid Vaccine Success

• 10/23/2024

  Merck’s RSV Breakthrough: Experimental Treatment Shields Infants